CNP (100 nM, 10 min) significantly decreased the baseline cAMP levels of PAH pericytes and this effect was prevented by the specific PDE2 inhibitor BAY 60-7550 (100 nM, 20 min pretreatment) (Fig. 5b). Here, CNP is linked to pulmonary arterial hypertension.